Company page
Neovacs Sa
Neovacs SA is a public company listed on the French market under the ticker ALNEV. The company has a market capitalization of approximately €370,652. Neovacs focuses on developing innovative treatments for autoimmune diseases and allergies.
- Ticker
- ALNEV
- Market cap
- $370,652
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major